ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 17751 to 17773 of 17925 messages
Chat Pages: 717  716  715  714  713  712  711  710  709  708  707  706  Older
DateSubjectAuthorDiscuss
20/9/2022
15:24
That's very true
michelle74
20/9/2022
15:20
No, but it shows they are prepared to risk their capital in the same investment as ourselves.
david gruen
20/9/2022
15:15
These directors are always buying shares, but that doesn't mean they are good stock pickers.
apollocreed1
20/9/2022
14:17
Sounds like it.
david gruen
20/9/2022
14:01
Good news at last
michelle74
20/9/2022
13:12
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.
TLSA
-0.90%
+ Free Alerts
("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 29,318 common shares priced between $0.78 and $0.81 per share.

The acquisition takes Mr Cerrone's interests from 37.70% to 37.72%.

david gruen
20/9/2022
12:01
Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab
jpuff
09/9/2022
17:00
Chief medical officer buys more shares you have to have hope
michelle74
09/9/2022
15:24
What makes you think that?
david gruen
09/9/2022
15:22
Good news coming soon I think
michelle74
02/9/2022
12:11
lots and still worth diddly!
nerdofsteel
23/8/2022
11:38
depends, how many of these FREE shares you have!
abbynat
22/8/2022
17:06
sure, worth diddly squat tho....
nerdofsteel
20/8/2022
08:36
Anyone able to trade Accustem shares?
pennstreet
02/8/2022
17:03
there's a good chance i might forget to tune in!
abbynat
01/8/2022
17:58
Tiziana Life Sciences Announces Presentation at Alzheimer's Association International Conference® 2022 (AAIC®) Evaluating Intranasal anti-CD3 for the Potential Treatment of Alzheimer's Disease
jpuff
22/7/2022
11:04
Yes I think we all need a bit of much here
michelle74
21/7/2022
18:00
A bit of a bounce today perhaps on the back of Tesla better than expected profits lol
jpuff
18/7/2022
11:06
another CMO, what happened to the last one?
nerdofsteel
15/7/2022
22:24
Dr KS has resigned as ceo. Not necessarily a bad thing imho
jpuff
12/7/2022
17:27
I do miss those cosy fireside chats....hats off to these guys! What a sting......
fandagle
06/7/2022
16:35
Dr KS resigned from the board of Accustem. I think he remains on the Tiziana Life Sciences board
miidas
06/7/2022
14:58
That'll be dr Kunwsr Shailubhai M. B. A. Others on the board, as follows. . . . Ooh. Look who's there?. Tiziana Life Sciences Ltd executives and other stock owners filed with the SEC include:Gabriele Marco Antonio Cerrone M.B.A., MBAFounder & Exec. ChairmanDr. Kunwar Shailubhai M.B.A., Ph.D.CEO, Chief Scientific Officer & Exec. DirectorDr. Kunwar ShailubhaiCEO, Chief Scientific Officer & Exec. DirectorGabriele CerroneExecutive Chairman of the BoardPercy LomaxNon-Executive DirectorLeopoldo ZambelettiNon-Executive DirectorWilly SimonNon-Executive DirectorJohn BrancaccioNon-Executive DirectorP. CooperCompany SecretaryJames TrippChief Operating Officer, Head of Global Clinical OperationsTiziano LazzarettiChief Financial OfficerShailubhai KunwarChief Executive Officer, Chief Scientific Officer, DirectorProf. Roberto PellicciariConsultantDr. Napoleone FerraraChairman of Scientific Advisory BoardDr. Neil Graham M.P.H., M.D., MPHChief Medical OfficerDr. Thomas H. AdamsHead of Drug Devel. & Exec. DirectorKeeren ShahFin. DirectorAndrew Westwell Ph.D.Scientific FounderRichard Clarkson Ph.D.Scientific Founder
lean5gb
Chat Pages: 717  716  715  714  713  712  711  710  709  708  707  706  Older

Your Recent History

Delayed Upgrade Clock